![Ian Peikon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Peikon
Directeur Général chez
Cajal Neuroscience, Inc.
Profil
Ian Peikon is the founder of Cajal Neuroscience, Inc. since 2020, holding the title of Co-Chief Executive Officer.
Current jobs include Venture Partner at Lux Capital Group LLC since 2019 and Board Member at Plexium, Inc. since 2022.
Former job includes Director-Platform Biology & Technology at Kallyope, Inc. from 2015 to 2019.
Education includes an undergraduate degree from Duke University, conferred in 2009.
Postes actifs de Ian Peikon
| Sociétés | Poste | Début |
|---|---|---|
Lux Capital Group LLC
 Lux Capital Group LLC Investment ManagersFinance Lux Capital Group seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of energy, healthcare, technology, 3D printing, machine learning, artificial intelligence, computational imaging & recognition, new materials, holograms,fixers for future, internet of things, connected hardware and virtual reality. It provides financing for seed and early stage capital requirements with an investment size in the range of USD 0.1- 100 million. | Consultant / Advisor | - |
Cajal Neuroscience, Inc.
 Cajal Neuroscience, Inc. BiotechnologyHealth Technology Develops novel medicines for patients with neurodegenerative disorders | Directeur Général | 01/04/2020 |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Directeur/Membre du Conseil | 01/08/2022 |
Anciens postes connus de Ian Peikon
| Sociétés | Poste | Fin |
|---|---|---|
Kallyope, Inc.
 Kallyope, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of migraine and neurological problems | Corporate Officer/Principal | 01/10/2019 |
Formation de Ian Peikon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lux Capital Group LLC
Lux Capital Group LLC Investment ManagersFinance Lux Capital Group seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of energy, healthcare, technology, 3D printing, machine learning, artificial intelligence, computational imaging & recognition, new materials, holograms,fixers for future, internet of things, connected hardware and virtual reality. It provides financing for seed and early stage capital requirements with an investment size in the range of USD 0.1- 100 million. | Finance |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of migraine and neurological problems | Health Technology |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Develops novel medicines for patients with neurodegenerative disorders | Health Technology |
